Tag: biomedical
-
Trial Shows Smartphone App Finds More Heart Disease
Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits.
-
Students Win Prize, Start Company for Alzheimer’s Detection
A team of undergraduate students won first prize in a National Institutes of Health biomedical engineering contest for a headset device to diagnose early-stage Alzheimer’s disease.
-
App Screens for Liver Diseases with Eye Selfies
A computer science lab designed a smartphone app that detects tell-tale indicators of liver disease and pancreatic cancer by analyzing self-taken photos of a patient’s own eyes.
-
Trial Testing Nicotine Patch for Lung Inflammation
A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs.
-
Engineered T-Cell Company Acquired for $11.9 Billion
A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion.
-
Infographic – Vaccinations Changed the World
This chart, courtesy of Der Spiegel and Statista, shows how the incidence of several diseases has been reduced in the U.S. since the introduction of vaccines.
-
New App Promises To Provide Tailored Radiation Treatment
Using 3-D models of their patients, the app provides neurosurgeons with all the information they need for correct dosage.
-
App Users Report Lower Blood Glucose Levels
A study of individuals with diabetes using a mobile app to record blood glucose levels, reported more than a 1 percent average reduction in blood glucose readings after a median of 4 months.
-
Clinical Trial Okayed for Parkinson’s Drug Implant
A maker of implants for long-term release of drugs to treat chronic diseases says the Food and Drug Administration approved a clinical trial to test its implant for Parkinson’s disease.
-
Engineered Insulin-Producing Cells to Be Grown in Lab
A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes.